Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholangiocarcinoma Detection Using an Intraoperative Fluorescence Image Guided Approach With Bevacizumab-IRDye 800CW

NCT03620292 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT03620292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03620292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholangiocarcinoma Detection Using an Intraoperative Fluorescence Image Guided Approach With Bevacizumab-IRDye 800CW
Lead sponsor
University Medical Center Groningen
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 1, 2019
Completion date
December 1, 2021
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hilar cholangiocarcinoma